{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T00:13:06Z","timestamp":1748909586414,"version":"3.40.4"},"reference-count":14,"publisher":"S. Karger AG","issue":"4","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.karger.com\/Services\/SiteLicenses"},{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.karger.com\/Services\/SiteLicenses"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Urol Int"],"published-print":{"date-parts":[[2008]]},"abstract":"<jats:p>&lt;i&gt;Aim:&lt;\/i&gt; To evaluate the influence of doxazosin and finasteride on histologic findings in benign prostatic hyperplasia accompanied by prostatitis, and to examine the factors related with prostate carcinogenesis. &lt;i&gt;Materials and Methods:&lt;\/i&gt; Prostate tissue from 17 cases of prostatic hyperplasia were divided into three groups; group 1: no medication history, group 2: both doxazosin and finasteride for at least 6 months before surgery; group 3: doxazosin for a minimum of 6 months before transurethral resection. Formalin-fixed, paraffin-embedded sections were stained with hematoxylin and eosin stain and immunohistochemistry for COX-2, CD3, CD68, VEGF, and GSTP (glutathione S-transferase pi). &lt;i&gt;Results:&lt;\/i&gt; CD3 showed a tendency toward decreased staining intensity and extent in group 3 (p = 0.026, p = 0.004, respectively). CD68 showed a different staining extent among the three groups (p = 0.020). For VEGF, the staining extent showed different results between groups 2 and 3 (p = 0.044). There was no correlation between COX-2 and VEGF in group 1. However, a positive correlation between COX-2 and GSTP1 was demonstrated in group 2 (p = 0.000). &lt;i&gt;Conclusions:&lt;\/i&gt; Doxazosin-treated prostate tissue showed decreased inflammatory reaction. GSTP1 expression was decreased in combined treatment with doxazosin and finasteride. These findings suggest that finasteride may interfere with the anti-inflammatory reaction. Finasteride also decreases angiogenesis. However, the meaning of our observations is limited by small sample size.<\/jats:p>","DOI":"10.1159\/000167844","type":"journal-article","created":{"date-parts":[[2008,12,11]],"date-time":"2008-12-11T14:35:10Z","timestamp":1229006110000},"page":"441-446","source":"Crossref","is-referenced-by-count":9,"title":["Histologic Influence of Doxazosin and Finasteride in Benign Prostatic Hyperplasia Accompanying Chronic Inflammation"],"prefix":"10.1159","volume":"81","author":[{"given":"Dong Soo","family":"Park","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeong Yun","family":"Shim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"127","published-online":{"date-parts":[[2008,12,10]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016%2FS0022-5347%2805%2965140-3"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056%2FNEJMra021562"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097%2F01.ju.0000142058.99614.ff"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1054%2Fbjoc.1999.0986"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016%2FS0090-4295%2802%2901637-0"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016%2FS0022-5347%2805%2963960-2"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097%2F01.ju.0000101487.83730.80"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097%2F01.ju.0000108142.53241.47"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1046%2Fj.1464-410x.2001.02193.x"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038%2Fnature01322"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1046%2Fj.1464-410x.1999.00352.x"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097%2F01.ju.0000033280.29453.72"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016%2FS0090-4295%2800%2900674-9"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016%2FS0002-9440%2810%2965517-4"}],"container-title":["Urologia Internationalis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.karger.com\/Article\/Pdf\/167844","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.karger.com\/Article\/Pdf\/167844","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T23:34:54Z","timestamp":1745451294000},"score":1,"resource":{"primary":{"URL":"https:\/\/karger.com\/article\/doi\/10.1159\/000167844"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008]]},"references-count":14,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2008,12,1]]}},"URL":"https:\/\/doi.org\/10.1159\/000167844","archive":["Portico"],"relation":{},"ISSN":["0042-1138","1423-0399"],"issn-type":[{"type":"print","value":"0042-1138"},{"type":"electronic","value":"1423-0399"}],"subject":[],"published":{"date-parts":[[2008]]}}}